Table 3.
Median levels of interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-10 (IL-10), and interferon gamma (IFN-γ) in studied participants’ plasma samples.
| Variable | YYRL1 Group (N = 10) |
Beep Group (N = 10) |
MT Group (N = 10) |
pKW 2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | Baseline | Post-Effort | Recovery | pF | ||
| Median (Minimum–Maximum) | Median (Minimum–Maximum) | Median (Minimum–Maximum) | |||||||||||
| IL-2 (pg/mL) | 2.7 (1.5–4.6) |
2.6 (0.3–4.6) |
4.6 (0.6–8.3) |
0.061 | 1.5 (0.7–2.4) |
3.9 (1.3–17.5) |
1.2 (0.1–18.2) |
0.067 | 5.9 (3.2–9.1) |
3.3 (1.4–5.5)B |
6.0 (2.3–8.6) |
0.020 | <0.001 |
| ratio 1 | 1.1 (0.0–1.8) |
1.8 (0.1–4.4) |
3.8 (0.6–8.8) |
0.8 (0.2–13.5) |
0.6 (0.1–1.3) |
1.0 (0.3–2.1) |
<0.001 0.371 |
||||||
| IL-4 (pg/mL) | 1.2 (0.2–3.3)A |
1.7 (1.3–4.5) |
2.5 (1.2–5.3)C |
0.001 | 1.4 (0.3–25.1)A |
13.1 (7.2–27.8) |
7.2 (2.4–15.8) |
< 0.001 | 1.3 (0.5–2.5) |
0.7 (0.3–1.5) |
1.1 (0.4–2.4) |
0.122 | 0.150 |
| ratio | 1.8 (0.0–7.9) |
2.8 (1.2–7.9) |
9.7 (0.3–23.1) |
5.3 (0.1–15.2) |
0.5 (0.1–2.4) |
0.7 (0.4–2.4) |
<0.001 0.002 |
||||||
| IL-6 (pg/mL) | 1.4 (0.4–4.6) |
3.1 (1.3–7.9) |
2.1 (1.3–7.9) |
0.061 | 0.4 (0.1–20.6)A |
13.1 (2.6–17.9) |
2.1 (1.3–7.9) |
0.002 | 1.3 (0.3–3.0)A |
4.7 (2.3–6.2) |
4.0 (2.2–9.2)C |
0.002 | 0.039 |
| ratio | 2.3 (0.0–12.7) |
1.3 (0.4–6.4) |
34.0 (0.1–120.9) |
5.5 (0.1–21.6) |
2.9 (1.0–16.2) |
3.5 (1.0–12.0) |
0.004 0.075 |
||||||
| IL-10 (pg/mL) | 1.9 (0.8–6.6) |
3.9 (2.0–11.9)B |
11.2 (10.3–15.3)C |
< 0.001 | 1.8 (0.9–3.8)A |
5.9 (3.2–9.1) |
3.3 (0.7–5.0) |
0.007 | 1.5 (0.0–2.6) |
1.9 (1.1–2.9)B |
5.2 (3.0–13.4)C |
< 0.001 | 0.191 |
| ratio | 1.9 (1.0–3.9) |
5.5 (2.3–14.5) |
3.0 (1.0–9.5) |
1.7 (0.5–2.9) |
1.4 (0.5–56.6) |
3.6 (1.8–294.8) |
0.163 <0.001 |
||||||
| IFN- (pg/mL) |
1.7 (1.1–10.5) |
1.7 (0.1–6.4)B |
13.5 (11.2–19.0)C |
< 0.001 | 2.0 (1.1–15.2)A |
6.8 (4.1–17.7) |
6.3 (2.8–13.1)C |
0.007 | 3.3 (2.4–4.5)A |
5.0 (3.1–6.2) |
12.9 (5.7–18.3)C |
< 0.001 | 0.003 |
| ratio | 1.0 (0.0–1.3) |
7.8 (1.2–15.4) |
4.2 (0.3–14.1) |
2.5 (0.5–9.7) |
1.5 (1.0–2.4) |
3.8 (1.5–7.7) |
0.002 0.014 |
||||||
| IFN-IL-4 |
1.8 (0.4–10.7)A |
1.0 (0.0–5.1) |
6.3 (2.1–13.7) |
0.002 |
1.3 (0.6–6.1) |
0.5 (0.2–1.9) |
1.1 (0.2–3.2) |
0.202 |
2.3 (1.2–4.5)A |
8.2 (2.1–15.6) |
11.0 (5.8–39.2)C |
0.002 | 0.076 |
| ratio | 0.5 (0.0–3.0) |
3.7 (0.2–7.2) |
0.4 (0.1–2.3) |
0.6 (0.1–5.3) |
2.8 (0.9–12.9) |
5.2 (1.4–12.2) |
<0.001 0.010 |
||||||
1 Post-effort/baseline ratio or recovery/baseline ratio in “post-effort” column or “recovery” column, respectively. 2 Differences in baseline values or in ratio values among analyzed groups (YYRL1 vs. Beep vs. MT) were assessed using the Kruskal–Wallis analysis of ranks and the median test (pKW, Kruskal–Wallis p values for baseline values, post-effort/baseline ratio and for recovery/baseline ratio in upper row, middle row, or bottom row for each variable, respectively). For other abbreviations see Table 2.